Surge in NHS activity erodes margins at GHG

General Healthcare Group (GHG) is starting to feel the sting in the tail of NHS contracts after a massive surge in publicly-funded patients during the first half helped erode EBITDA margins to 21.2% from 26.8% a year earlier.